Contributions of IRF5 to Chikungunya Viral Arthritis

IRF5 对基孔肯雅病毒性关节炎的贡献

基本信息

  • 批准号:
    10541650
  • 负责人:
  • 金额:
    $ 5.23万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2021
  • 资助国家:
    美国
  • 起止时间:
    2021-12-21 至 2022-02-28
  • 项目状态:
    已结题

项目摘要

Project Summary/Abstract The goal of this proposal is to develop the applicant into an independent investigator with a research program that examines the intersection of autoimmunity and antiviral immunity. The principal investigator (PI) previously received his PhD training in biochemistry and molecular biology while studying immune mechanisms of leukocyte trafficking at the Oklahoma Medical Research Foundation. As of 2015, the PI has completed his clinical training in internal medicine and rheumatology and is currently a post-doctoral fellow receiving formal training in immunology and virology at Washington University in Saint Louis. The mentor is Dr. Michael Diamond, Professor of Medicine at Washington University, Associate Director of the Center for Human Immunology and Immunotherapy Programs, and an established leader in the fields of innate immunity and viral pathogenesis. Dr. Diamond has over 270 publications with special expertise in studies of flaviviruses (e.g., West Nile, Dengue, and Zika viruses) and alphaviruses (e.g., Chikungunya virus). Dr. Diamond is an infectious disease specialist who provides a model of a successful physician-scientist to the applicant at Washington University, an internationally recognized premier academic institution. Chikungunya virus (CHIKV) is an arthritogenic alphavirus that causes acute and chronic synovitis in a distribution that mimics seronegative rheumatoid arthritis. Epidemiological studies conducted after the Reunion Island CHIKV outbreak in 2006 suggest that a majority of patients infected with CHIKV progress to chronic arthralgias and arthritis. At present, the role of specific interferon (IFN) stimulated genes and transcription factors during CHIKV infection is still being defined. IFN regulatory factor (IRF)5 is a transcription factor that is activated during viral infection and is known to upregulate expression of IFN stimulated genes, promote production of proinflammatory cytokines, and enhance apoptosis under certain conditions. Polymorphisms resulting in overexpression of human IRF5 are associated with the risk of developing systemic lupus erythematosus and rheumatoid arthritis. We hypothesize that the severity and duration of CHIKV arthritis also may be related to IRF5 polymorphisms that modulate the antiviral immune response during acute infection. Here, we propose to test the contribution of IRF5 expression globally and in specific cell types using an established mouse model of CHIKV arthritis. We also propose to generate knock-in mice that ectopically express IRF5 to test the effect of IRF5 gene dosage on the pathogenesis of CHIKV arthritis. Using these approaches, the applicant will gain expertise in immunology, virology, autoimmunity, and viral arthritis. This will establish a foundation for an independent research program that will study interactions between host genetic risk factors and pathogens that may act to trigger chronic rheumatologic diseases.
项目总结/文摘

项目成果

期刊论文数量(8)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Regulation of cGAS and STING signaling during inflammation and infection.
  • DOI:
    10.1016/j.jbc.2023.104866
  • 发表时间:
    2023-07
  • 期刊:
  • 影响因子:
    4.8
  • 作者:
    Chauvin, Samuel D.;Stinson, W. Alexander;Platt, Derek J.;Poddar, Subhajit;Miner, Jonathan J.
  • 通讯作者:
    Miner, Jonathan J.
STING-associated vasculopathy develops independently of IRF3 in mice.
  • DOI:
    10.1084/jem.20171351
  • 发表时间:
    2017-11-06
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Warner JD;Irizarry-Caro RA;Bennion BG;Ai TL;Smith AM;Miner CA;Sakai T;Gonugunta VK;Wu J;Platt DJ;Yan N;Miner JJ
  • 通讯作者:
    Miner JJ
Consequences of congenital Zika virus infection.
先天性寨卡病毒感染的后果。
  • DOI:
    10.1016/j.coviro.2017.09.005
  • 发表时间:
    2017
  • 期刊:
  • 影响因子:
    5.9
  • 作者:
    Platt,DerekJ;Miner,JonathanJ
  • 通讯作者:
    Miner,JonathanJ
Lesion evolution and neurodegeneration in RVCL-S: A monogenic microvasculopathy.
  • DOI:
    10.1212/wnl.0000000000010659
  • 发表时间:
    2020-10-06
  • 期刊:
  • 影响因子:
    9.9
  • 作者:
    Ford AL;Chin VW;Fellah S;Binkley MM;Bodin AM;Balasetti V;Taiwo Y;Kang P;Lin D;Jen JC;Grand MG;Bogacki M;Liszewski MK;Hourcade D;Chen Y;Hassenstab J;Lee JM;An H;Miner JJ;Atkinson JP
  • 通讯作者:
    Atkinson JP
The IFN-γ receptor promotes immune dysregulation and disease in STING gain-of-function mice.
  • DOI:
    10.1172/jci.insight.155250
  • 发表时间:
    2022-09-08
  • 期刊:
  • 影响因子:
    8
  • 作者:
    Stinson, W. Alexander;Miner, Cathrine A.;Zhao, Fang R.;Lundgren, Annena Jane;Poddar, Subhajit;Miner, Jonathan J.
  • 通讯作者:
    Miner, Jonathan J.
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Jonathan J Miner其他文献

MDA5 and autoimmune disease
MDA5 与自身免疫性疾病
  • DOI:
    10.1038/ng.2959
  • 发表时间:
    2014-04-28
  • 期刊:
  • 影响因子:
    29.000
  • 作者:
    Jonathan J Miner;Michael S Diamond
  • 通讯作者:
    Michael S Diamond

Jonathan J Miner的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Jonathan J Miner', 18)}}的其他基金

Role of TREX1 in age-related hereditary leukoencephalopathy
TREX1 在年龄相关遗传性白质脑病中的作用
  • 批准号:
    10803373
  • 财政年份:
    2023
  • 资助金额:
    $ 5.23万
  • 项目类别:
Mechanisms of STING-associated immunodeficiency
STING 相关免疫缺陷的机制
  • 批准号:
    10117178
  • 财政年份:
    2019
  • 资助金额:
    $ 5.23万
  • 项目类别:
Mechanisms of STING-associated immunodeficiency
STING 相关免疫缺陷的机制
  • 批准号:
    10571901
  • 财政年份:
    2019
  • 资助金额:
    $ 5.23万
  • 项目类别:
Mechanisms of STING-associated immunodeficiency
STING 相关免疫缺陷的机制
  • 批准号:
    10339404
  • 财政年份:
    2019
  • 资助金额:
    $ 5.23万
  • 项目类别:
Contributions of IRF5 to Chikungunya Viral Arthritis
IRF5 对基孔肯雅病毒性关节炎的贡献
  • 批准号:
    9224103
  • 财政年份:
    2017
  • 资助金额:
    $ 5.23万
  • 项目类别:
Contributions of IRF5 to Chikungunya Viral Arthritis
IRF5 对基孔肯雅病毒性关节炎的贡献
  • 批准号:
    10075631
  • 财政年份:
    2017
  • 资助金额:
    $ 5.23万
  • 项目类别:

相似国自然基金

rs4728142调控IRF5表达对阿尔茨海默病的作用和机制研究
  • 批准号:
    ZYQ25H090001
  • 批准年份:
    2025
  • 资助金额:
    0.0 万元
  • 项目类别:
    省市级项目
TRAF6/IRF5通过介导小胶质细胞胞葬作用调控AD神经炎症的功能与机制研究
  • 批准号:
    QN25H090041
  • 批准年份:
    2025
  • 资助金额:
    0.0 万元
  • 项目类别:
    省市级项目
基于 IRF5 基因敲除小鼠模型探究 NLRP3 炎症 小体介导溃疡性结肠炎的分子机制研究
  • 批准号:
    TGD24H030003
  • 批准年份:
    2024
  • 资助金额:
    0.0 万元
  • 项目类别:
    省市级项目
Ikkβ激活Irf5信号通路调控巨噬细胞功能在肌萎缩侧索硬化病情进 展中的分子机制研究
  • 批准号:
  • 批准年份:
    2024
  • 资助金额:
    0.0 万元
  • 项目类别:
    省市级项目
ID2 调 控 IRF5 抑 制 肺 泡 巨 噬 细 胞 M1 极 化 缓 解 ALI/ARDS 进展的机制研究
  • 批准号:
    2024JJ5609
  • 批准年份:
    2024
  • 资助金额:
    0.0 万元
  • 项目类别:
    省市级项目
基于IRF5/MYD88信号通路调控巨噬细胞M1极化探讨针刀刺营治疗急性扁桃体炎的机制研究
  • 批准号:
    82360957
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    地区科学基金项目
IRF5调控肝损伤的表观代谢机制与治疗性研究
  • 批准号:
    LTGY23H030001
  • 批准年份:
    2023
  • 资助金额:
    0.0 万元
  • 项目类别:
    省市级项目
巨噬细胞IRF5激活Notch2-MMP9信号通路促进先天性梗阻性肾病肾纤维化的机制研究
  • 批准号:
    82371709
  • 批准年份:
    2023
  • 资助金额:
    49 万元
  • 项目类别:
    面上项目
短链脂肪酸通过IRF5/RANTES途径抑制小胶质细胞活化迁移改善脓毒症脑病的机制研究
  • 批准号:
  • 批准年份:
    2022
  • 资助金额:
    33 万元
  • 项目类别:
    地区科学基金项目
IRF5 介导肺巨噬细胞极化在结缔组织病相关间质性肺疾病免疫应答中的作用机制研究
  • 批准号:
    2022JJ40714
  • 批准年份:
    2022
  • 资助金额:
    0.0 万元
  • 项目类别:
    省市级项目

相似海外基金

転写因子IRF5の活性化後における自身の分解と自己免疫疾患の関連性
转录因子IRF5激活后的自降解与自身免疫性疾病的关系
  • 批准号:
    23K14548
  • 财政年份:
    2023
  • 资助金额:
    $ 5.23万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Determining the role of transcription factor Irf5 in regulating microglial transcriptional and cellular activities in the demyelinating brain
确定转录因子 Irf5 在调节脱髓鞘脑中小胶质细胞转录和细胞活动中的作用
  • 批准号:
    458442
  • 财政年份:
    2021
  • 资助金额:
    $ 5.23万
  • 项目类别:
    Studentship Programs
New role(s) for IRF5 as a regulator of tau accumulation in Alzheimer’s disease
IRF5 在阿尔茨海默病中调节 tau 蛋白积累的新作用
  • 批准号:
    10302599
  • 财政年份:
    2021
  • 资助金额:
    $ 5.23万
  • 项目类别:
Determining the role of transcription factor Irf5 in regulating microglial transcriptional and cellular activities in the demyelinating brain
确定转录因子 Irf5 在调节脱髓鞘脑中小胶质细胞转录和细胞活动中的作用
  • 批准号:
    428794
  • 财政年份:
    2019
  • 资助金额:
    $ 5.23万
  • 项目类别:
    Studentship Programs
IRF5 and Macrophage Activation Syndrome in systemic Juvenile Idiopathic Arthritis
系统性幼年特发性关节炎中的 IRF5 和巨噬细胞激活综合征
  • 批准号:
    10199939
  • 财政年份:
    2019
  • 资助金额:
    $ 5.23万
  • 项目类别:
IRF5 and Macrophage Activation Syndrome in systemic Juvenile Idiopathic Arthritis
系统性幼年特发性关节炎中的 IRF5 和巨噬细胞激活综合征
  • 批准号:
    10454915
  • 财政年份:
    2019
  • 资助金额:
    $ 5.23万
  • 项目类别:
IRF5 and Macrophage Activation Syndrome in systemic Juvenile Idiopathic Arthritis
系统性幼年特发性关节炎中的 IRF5 和巨噬细胞激活综合征
  • 批准号:
    9982787
  • 财政年份:
    2019
  • 资助金额:
    $ 5.23万
  • 项目类别:
IRF5 and Macrophage Activation Syndrome in systemic Juvenile Idiopathic Arthritis
系统性幼年特发性关节炎中的 IRF5 和巨噬细胞激活综合征
  • 批准号:
    10663266
  • 财政年份:
    2019
  • 资助金额:
    $ 5.23万
  • 项目类别:
Contributions of IRF5 to Chikungunya Viral Arthritis
IRF5 对基孔肯雅病毒性关节炎的贡献
  • 批准号:
    9224103
  • 财政年份:
    2017
  • 资助金额:
    $ 5.23万
  • 项目类别:
Contributions of IRF5 to Chikungunya Viral Arthritis
IRF5 对基孔肯雅病毒性关节炎的贡献
  • 批准号:
    10075631
  • 财政年份:
    2017
  • 资助金额:
    $ 5.23万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了